In the LPS-induced model of SAKI, it has been demonstrated that the suppression of abnormal immune responses through inhibition of the TLR4/NF-κB pathway might prevent AKI and improve the clinical outcome of sepsis. The gene discussed is TLR4; the disease is acute kidney injury.